» Articles » PMID: 25511085

MicroRNAs in Myocardial Infarction

Overview
Journal Nat Rev Cardiol
Date 2014 Dec 17
PMID 25511085
Citations 175
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that block translation or induce degradation of mRNA and thereby control patterns of gene expression. Acute myocardial infarction is a common cardiovascular event that results in cardiac remodelling and can consequently lead to the development of chronic heart failure. Several miRNAs have been shown to control important processes that contribute to the pathophysiological consequences of acute myocardial infarction. miRNAs can either promote or inhibit cardiomyocyte cell death, and also regulate postischaemic neovascularization. Cardiac regeneration can also be regulated by miRNAs that control cardiomyocyte proliferation or interfere with cardioprotective effects mediated by stem or progenitor cells. miRNAs can also be used for direct reprogramming of cardiac fibroblasts into cardiomyocytes. In this Review, we focus on the current understanding of the role of miRNAs in these processes, and particularly discuss the therapeutic potential of miRNAs in treating acute myocardial infarction.

Citing Articles

Identification of the CeRNA axis of circ_0000006/miR-483-5p/KDM2B in the progression of aortic aneurysm to aorta dissection.

Liu Y, Tan X, Wang L, Jin W, He Y, Yan Y BMC Cardiovasc Disord. 2025; 25(1):141.

PMID: 40021969 PMC: 11869725. DOI: 10.1186/s12872-025-04598-8.


Alternative splicing factors and cardiac disease: more than just missplicing?.

Gregorich Z, Guo W RNA. 2025; 31(3):300-306.

PMID: 39773891 PMC: 11874993. DOI: 10.1261/rna.080332.124.


X-Chromosome-Linked miRNAs Regulate Sex Differences in Cardiac Physiology.

Emerson J, Shi W, Paredes-Larios J, Walker W, Hutton J, Cristea I Circ Res. 2025; 136(3):258-275.

PMID: 39772608 PMC: 11781965. DOI: 10.1161/CIRCRESAHA.124.325447.


Elevated miRNA-499 Levels in Early Phase of Non-ST Elevation Acute Coronary Syndromes Predict Increased Long-Term Risk of Major Adverse Cardiac Events.

Miskowiec D, Szymczyk E, Wejner-Mik P, Michalski B, Lipiec P, Simiera M J Clin Med. 2025; 13(24.

PMID: 39768724 PMC: 11727993. DOI: 10.3390/jcm13247803.


A Thorough Navigation of miRNA's Blueprint in Crafting Cardiovascular Fate.

Nazir A, Uwishema O, Shariff S, Franco W, El Masri N, Ayele N Health Sci Rep. 2024; 7(11):e70136.

PMID: 39502130 PMC: 11535861. DOI: 10.1002/hsr2.70136.


References
1.
Semo J, Sharir R, Afek A, Avivi C, Barshack I, Maysel-Auslender S . The 106b∼25 microRNA cluster is essential for neovascularization after hindlimb ischaemia in mice. Eur Heart J. 2013; 35(45):3212-23. DOI: 10.1093/eurheartj/eht041. View

2.
Wang L, Huang H, Fan Y, Kong B, Hu H, Hu K . Effects of downregulation of microRNA-181a on H2O2-induced H9c2 cell apoptosis via the mitochondrial apoptotic pathway. Oxid Med Cell Longev. 2014; 2014:960362. PMC: 3942394. DOI: 10.1155/2014/960362. View

3.
Ren X, Wu J, Wang X, Sartor M, Jones K, Qian J . MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation. 2009; 119(17):2357-2366. PMC: 2746735. DOI: 10.1161/CIRCULATIONAHA.108.814145. View

4.
Katare R, Riu F, Mitchell K, Gubernator M, Campagnolo P, Cui Y . Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res. 2011; 109(8):894-906. PMC: 3623091. DOI: 10.1161/CIRCRESAHA.111.251546. View

5.
Bernardo B, Gao X, Winbanks C, Boey E, Tham Y, Kiriazis H . Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci U S A. 2012; 109(43):17615-20. PMC: 3491509. DOI: 10.1073/pnas.1206432109. View